Clinical Trial Update: Effects of ABT-089 on Smoking Abstinence Symptoms and Reward [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ABT-089 on smoking abstinence symptoms and reward in tobacco use disorder. The study was terminated and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• ABT-089

Snippet

Sponsor: University of Pennsylvania | Conditions: Nicotine Addiction | Phase 2 | Status: TERMINATED | Results posted: 2014-10-29